JPMORGAN CHASE & CO - ORTHO CLINICAL DIAGNOSTICS H ownership

ORTHO CLINICAL DIAGNOSTICS H's ticker is OCDX and the CUSIP is G6829J107. A total of 1 filers reported holding ORTHO CLINICAL DIAGNOSTICS H in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ORTHO CLINICAL DIAGNOSTICS H
ValueSharesWeighting
Q1 2022$159,413,000
+7.4%
8,543,032
+23.1%
0.02%
+11.8%
Q4 2021$148,479,000
+43.8%
6,941,490
+24.2%
0.02%
+30.8%
Q3 2021$103,287,000
-9.6%
5,589,124
+4.7%
0.01%
-7.1%
Q2 2021$114,290,000
+12.4%
5,338,175
+1.3%
0.01%0.0%
Q1 2021$101,705,0005,271,0660.01%
Other shareholders
ORTHO CLINICAL DIAGNOSTICS H shareholders Q2 2022
NameSharesValueWeighting ↓
Carlyle Group Inc. 143,406,000$3,070,322,00020.78%
SECTORAL ASSET MANAGEMENT INC 1,286,750$27,549,0002.23%
SHAPIRO CAPITAL MANAGEMENT LLC 5,566,581$119,180,0002.07%
Eversept Partners, LP 1,394,284$29,851,6201.99%
CRAMER ROSENTHAL MCGLYNN LLC 1,683,200$36,037,0001.16%
ARMISTICE CAPITAL, LLC 1,672,000$35,798,0000.64%
Alyeska Investment Group, L.P. 2,436,189$52,159,0000.60%
Ghisallo Capital Management LLC 426,864$9,139,0000.35%
BRANT POINT INVESTMENT MANAGEMENT LLC 155,000$3,319,0000.31%
Polar Asset Management Partners Inc. 1,275,196$27,302,0000.28%
View complete list of ORTHO CLINICAL DIAGNOSTICS H shareholders